General Information of Drug Transporter (DT)
DT ID DTD0263 Transporter Info
Gene Name SLC2A5
Transporter Name Glucose transporter type 5, small intestine
Gene ID
6518
UniProt ID
P22732
Post-Translational Modification of This DT
Overview of SLC2A5 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-N-glycosylation X-Phosphorylation X: Amino Acid

Acetylation

  Methionine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A5 [1]

Role of PTM

Potential impacts

Modified Residue

Methionine

Modified Location

1

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC2A5 Methionine 1 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A5 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

51

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC2A5 Asparagine 51 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A5 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

124

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A5 Serine 124 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A5 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

131

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A5 Serine 131 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC2A5 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

242

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A5 Serine 242 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC2A5 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

482

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A5 Serine 482 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A5 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

123

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A5 Threonine 123 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A5 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

199

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A5 Threonine 199 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A5 [9]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

485

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A5 Tyrosine 485 has the potential to affect its expression or activity.
References
1 N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54.
2 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: GTR5_HUMAN)
3 Opposite Electron-Transfer Dissociation and Higher-Energy Collisional Dissociation Fragmentation Characteristics of Proteolytic K/R(X)n and (X)nK/R Peptides Provide Benefits for Peptide Sequencing in Proteomics and Phosphoproteomics. J Proteome Res. 2017 Feb 3;16(2):852-861.
4 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
5 Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.
6 Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells. Mol Cell Proteomics. 2017 Jul;16(7):1365-1376.
7 Selective phosphorylation during early macrophage differentiation. Proteomics. 2015 Nov;15(21):3731-43.
8 Motif-specific sampling of phosphoproteomes. J Proteome Res. 2008 May;7(5):2140-50.
9 Quantitative phosphoproteomics analysis reveals a key role of insulin growth factor 1 receptor (IGF1R) tyrosine kinase in human sperm capacitation. Mol Cell Proteomics. 2015 Apr;14(4):1104-12.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.